Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001, 357 (Pt 3): 593-615. 10.1042/0264-6021:3570593.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH: Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A. 1992, 89 (15): 6711-6715.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ: Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 1992, 90 (5): 2092-2096.
Article
PubMed Central
CAS
PubMed
Google Scholar
Koshland DE: The molecule of the year. Science. 1992, 258 (5090): 1861.
Article
PubMed
Google Scholar
Hayden MR: Atherosclerosis and plaque Angiogenesis: a malignant transformation. Submitted paper. Pathology and Clinical classification of Vulnerable Plaque.May 2001, http://www.vp.orghttp://www.vp.org/ResourceCenter/Pete_Hayden_Angiogenesis.html.
Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002, 105 (14): 1656-1662. 10.1161/01.CIR.0000012748.58444.08.
Article
CAS
PubMed
Google Scholar
Hayden MR, Tyagi SC: Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. JOP J Pancreas (online). 2002, 3 (4): 86-108. [http://www.joplink.net]
Google Scholar
Hayden MR, Tyagi SC: Intimal Redox Stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovascular Diabetology. 2002, 1:3: [http://www.cardiab.com]
Google Scholar
Hayden MR, Tyagi SC: Arterial vascular remodeling: the endothelial cell's central role. Mo Med. 1998, 95 (5): 213-217.
CAS
PubMed
Google Scholar
Hayden MR, Tyagi SC: Chapter. Atherosclerosis: Implications of angiotensin II and the AT-1 receptor. Angiotensin II Receptor Blockade: Physiological and Clinical Implications. Edited by: Dhalla NS, Zahradka P, Dixon I, Beamish R. 1998, Kluwer Academic publishers. Boston, Ma, 2: 233-243.
Chapter
Google Scholar
Hayden MR, Tyagi SC: Arteriogenesis: Angiogenesis within Unstable Atherosclerotic Plaques – Interactions with Extracellular Matrix. Curr Interv Cardiol Rep. 2000, 2 (3): 218-227.
PubMed
Google Scholar
Hayden MR: Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus. JOP J Pancreas (online). 2002, 3 (5): 86-108. [http://www.joplink.net]
Google Scholar
Kroncke KD, Fehsel K, Kolb-Bachofen V: Nitric oxide: cytotoxicity versus cytoprotection – how, why, when, and where?. Nitric Oxide. 1997, 1 (2): 107-120. 10.1006/niox.1997.0118.
Article
CAS
PubMed
Google Scholar
Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS: Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002, 287 (11): 1420-1426. 10.1001/jama.287.11.1420.
Article
PubMed
Google Scholar
Cooke JP, Oka RK: Atherogenesis and the arginine hypothesis. Curr Atheroscler Rep. 2001, 3 (3): 252-259.
Article
CAS
PubMed
Google Scholar
Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP: Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 2002, 106 (8): 987-992. 10.1161/01.CIR.0000027109.14149.67.
Article
CAS
PubMed
Google Scholar
Cooke JP: Does ADMA cause endothelial dysfunction?. Arterioscler Thromb Vasc Biol. 2000, 20 (9): 2032-2037.
Article
CAS
PubMed
Google Scholar
Nash DT: Insulin resistance, ADMA levels, and cardiovascular disease. JAMA. 2002, 287 (11): 1451-1452. 10.1001/jama.287.11.1451.
Article
PubMed
Google Scholar
Faldetta CM, Laurenti O, Desideri G, Bravi MC, DeLuca O, Marinucci MC, De Mattia G, Ferri C: L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in type II diabetic patients. Diabetologia. 2002, 45: 1120-1127. 10.1007/s00125-002-0854-1.
Article
Google Scholar
Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, Scherrer U: Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001, 104: 342-345.
Article
CAS
PubMed
Google Scholar
Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 1998, 32: 3-8.
Article
CAS
PubMed
Google Scholar
Shimasaki Y, Vasue H, Yoshimura M, Nakayama M, Kaugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K: Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 1998, 31 (7): 1506-1510. 10.1016/S0735-1097(98)00167-3.
Article
CAS
PubMed
Google Scholar
Hingorani AD, Liang CF, Fatibene J, Lyon Monteith AS, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ: A common variant of the endothelial nitric oxide synthase (Glu298 → Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999, 100 (14): 1515-1520.
Article
CAS
PubMed
Google Scholar
Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Massetti S, Rossi G, Clerico A, Biagini A: Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298 → Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart. 2002, 87 (6): 525-528. 10.1136/heart.87.6.525.
Article
PubMed Central
CAS
PubMed
Google Scholar
Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, De Leeuw PW, Smits P: The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens. 2002, 20 (10): 2023-2027. 10.1097/00004872-200210000-00022.
Article
CAS
PubMed
Google Scholar
Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y, Nishijima S, Yokomizo T, Tokunaga K, Fujita T: Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002, 40 (4): 535-540. 10.1161/01.HYP.0000033974.57407.82.
Article
CAS
PubMed
Google Scholar
Werner-Felmayer G, Golderer G, Werner ER: Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Current Drug Metabolism. 2002, 3: 159-173.
Article
CAS
PubMed
Google Scholar
Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J: Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 2002, 105 (1): 22-26. 10.1161/hc0102.101388.
Article
CAS
PubMed
Google Scholar
Van Etten RW, De Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ: Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia. 2002, 45 (7): 1004-1010. 10.1007/s00125-002-0862-1.
Article
CAS
PubMed
Google Scholar
Boger R, Bode-Boger S, Thiele W: Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol. 1998, 32: 1336-1344. 10.1016/S0735-1097(98)00375-1.
Article
CAS
PubMed
Google Scholar
Maxwell AJ, Anderson BA, Cooke JP: Nutritional therapy for peripherial arterial disease: A double blind, placebo-controlled, randomized trial of HeartBar. Vasc Med. 2000, 5: 11-19. 10.1191/135886300676721584.
CAS
PubMed
Google Scholar
Tyagi SC: Homocyst(e)ine and heart disease: Pathophysiology of extracellular matrix. Clin Exper Hypertens. 1999, 21 (3): 181-198.
Article
CAS
Google Scholar
Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC: Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens. 2002, 15 (2 Pt 1): 157-163. 10.1016/S0895-7061(01)02286-5.
Article
CAS
PubMed
Google Scholar
Mujumdar VS, Tummalapalli CM, Aru GM, Tyagi SC: Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR. Am J Physiol Cell Physiol. 2002, 282 (5): C1009-1015.
Article
CAS
PubMed
Google Scholar
Mujumdar VS, Aru GM, Tyagi SC: Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem. 2001, 82 (3): 491-500. 10.1002/jcb.1175.
Article
CAS
PubMed
Google Scholar
Mujumdar VS, Hayden MR, Tyagi SC: Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol. 2000, 183 (1): 28-36. 10.1002/(SICI)1097-4652(200004)183:1<28::AID-JCP4>3.0.CO;2-O.
Article
CAS
PubMed
Google Scholar
Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC: Hyperhomocyst(e)inemia induces multi organ damage. Heart Vessels. 2000, 15 (3): 135-143. 10.1007/s003800070030.
Article
CAS
PubMed
Google Scholar
Stanger O: Physiology of folic acid in health and disease. Current Drug Metabolsim. 2002, 3 (2): 211-223.
Article
CAS
Google Scholar
Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM: Effect of homocysteine-lowering therapy with folic Acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the swiss heart study: a randomized controlled trial. JAMA. 2002, 288 (8): 973-979. 10.1001/jama.288.8.973.
Article
CAS
PubMed
Google Scholar
Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM: Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. Eur Heart J. 2002, 23 (9): 726-33. 10.1053/euhj.2001.2962.
Article
CAS
PubMed
Google Scholar
Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM: Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 2001, 345 (22): 1593-600. 10.1056/NEJMoa011364.
Article
CAS
PubMed
Google Scholar
Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999, 100: 1134-1146.
Article
CAS
PubMed
Google Scholar
Roy D, Perreault M, Marette A: Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. AJP-Endocrinology and Metabolism. 1998, 274 (4): E692-E699.
CAS
Google Scholar
Kapur S, Bedard S, Marcotte B, Cote CH, Marette A: Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes. 1997, 46 (11): 1691-1700.
Article
CAS
PubMed
Google Scholar
Shiuchi T, Cui TX, Wu L, Nakagami H, Takeda-Matsubara Y, Iwai M, Horiuchi M: ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension. 2002, 40 (3): 329-334. 10.1161/01.HYP.0000028979.98877.0C.
Article
CAS
PubMed
Google Scholar
Gæde P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348: 383-393. 10.1056/NEJMoa021778.
Article
PubMed
Google Scholar
Solomon CG: Reducing cardiovascular risk in type 2 diabetes. N Engl J Med. 2003, 348: 457-459. 10.1056/NEJMe020172.
Article
PubMed
Google Scholar